Up to 3% of LS cases are due to variants involving the 3’ end of the EPCAM gene (immediately adjacent to MSH2), which result in hypermethylation of the MSH2 promoter or partial deletion of MSH2 (6, 7). The gene discussed is EPCAM; the disease is Leigh syndrome.